To see the other types of publications on this topic, follow the link: Organophosphate induced delayed neuropathy.

Journal articles on the topic 'Organophosphate induced delayed neuropathy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Organophosphate induced delayed neuropathy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Eyer, P. "Review : Neuropsychopathological changes by organophosphorus compounds — a review." Human & Experimental Toxicology 14, no. 11 (1995): 857–64. http://dx.doi.org/10.1177/096032719501401101.

Full text
Abstract:
1 Available literature dealing with neuropsychopathologi cal changes after exposure to organophosphate insecti cides is reviewed. 2 Subacute neurological sequelae following acute organophosphate intoxication include the 'intermediate syndrome', probably a myopathy elicited by excess acetylcholine, and the 'organophosphate-induced delayed neuropathy' (OPIDN), which is caused by particularly neurotoxic organophosphates that inhibit neuropathy target esterase. 3 Long-term toxic effects affecting behaviour as well as mental and visual functions are occasionally observed after exposure to high dose
APA, Harvard, Vancouver, ISO, and other styles
2

Vasconcellos, Luiz Felipe R., Ana Cláudia Leite, and Osvaldo J. M. Nascimento. "Organophosphate-induced delayed neuropathy: case report." Arquivos de Neuro-Psiquiatria 60, no. 4 (2002): 1003–7. http://dx.doi.org/10.1590/s0004-282x2002000600022.

Full text
Abstract:
Organophosphate induced delayed neuropathy (OPIDN) is an uncommon clinical condition. It occurs in association with the ingestion of great amounts of organophosphate after the stimulation of cholinergic receptor. The clinical picture is characterized by a distal paresis in lower limbs associated with sensitive symptoms. Electrodiagnostic studies show a motor axonal neuropathy. Involvement of the central nervous system may occur. We describe a 39 years-old female patient who developed hyperesthesia associated with lower limbs paresis, fourteen days after she had ingested a Dichlorvos-based inse
APA, Harvard, Vancouver, ISO, and other styles
3

Basak, PM, MM Begum, MJ Islam, FA Khan, HS Das, and KI Jahan. "Organophosphate Induced Delayed Neuropathy (OPIDN)." TAJ: Journal of Teachers Association 27, no. 1 (2018): 62–63. http://dx.doi.org/10.3329/taj.v27i1.37617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shukla, Abhiranjan, Dharampal Anand, and Ravindra Urkude. "Organophosphate induced delayed pure motor neuropathy." Journal of Neurology, Neurosurgery & Psychiatry 88, no. 5 (2017): e1.43-e1. http://dx.doi.org/10.1136/jnnp-2017-316074.45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Prasai, Pratik, Jitendra Thakur, and Karuna Tamrakar Karki. "Organophosphorus Poisoning Induced Delayed Poly-axonal Motor Neuropathy: A Case Report." Eastern Green Neurosurgery 4, no. 1 (2022): 27–29. http://dx.doi.org/10.3126/egn.v4i1.51012.

Full text
Abstract:
Organophosphate being the lethal compound and easily available insecticide in the developing countries has significant potential health risk. The morbidity related to organophosphate poisoning as delayed peripheral neuropathy, extra pyramidal syndromes and neuropsychiatric manifestations are still the major consequences of secondary neuronal damage. Herein, we present a case of 23 year old lady who ingested organophosphate in the context of suicidal attempt and presented with motor neuropathy after 4 weeks.
APA, Harvard, Vancouver, ISO, and other styles
6

International, Journal of Medical Science and Advanced Clinical Research (IJMACR). "Organophosphorus (Chlorpyrifos) Toxicity Causing Delayed Induced Neuropathy and Myelopathy - Rare Case Report." International Journal of Medical Science and Advanced Clinical Research (IJMACR) 8, no. 2 (2025): 42–47. https://doi.org/10.5281/zenodo.15239883.

Full text
Abstract:
<strong>Abstract</strong> Organophosphate (OP) poisoning is the most common poisoning in India, accounting for almost half of the hospital admissions due to poisoning. Delayed neuropathy is initiated by an attack on a nervous tissue esterase. Although uncommon, delayed neurotoxicity has been consistently reported in literature. This mechanism is implicated not only in damaging peripheral nervous system but also in causing central processes leading to myelopathy. We report a case report of 35year old male who came to our hospital with delayed neurological manifestations of organophosphorus pois
APA, Harvard, Vancouver, ISO, and other styles
7

Akçay Yalbuzdag, Şeniz. "Organophosphate induced delayed neuropathy: a case report." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 63, no. 1 (2017): 88–91. http://dx.doi.org/10.5606/tftrd.2017.13549.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gao, Zhaobing, Qiang Ding, Xin Xie, Bernard Attali, and Jian Li. "TRPA1 channel mediates organophosphate-induced delayed neuropathy." Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): PO1–1–124. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_po1-1-124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

GLYNN, P. "A mechanism for organophosphate-induced delayed neuropathy." Toxicology Letters 162, no. 1 (2006): 94–97. http://dx.doi.org/10.1016/j.toxlet.2005.10.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Qiang, D., X. Xie, and Z. Gao. "New insights into the organophosphate-induced delayed neuropathy." Journal of the Neurological Sciences 381 (October 2017): 153–54. http://dx.doi.org/10.1016/j.jns.2017.08.451.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Rao, Bangam Rajendra Prasad, Lalatendu Mohanty, Himavanta Kampali, et al. "Organophosphate-induced delayed neuropathy: A rare case presentation." Journal of Integrative Medicine and Research 2, no. 1 (2024): 33–36. http://dx.doi.org/10.4103/jimr.jimr_46_23.

Full text
Abstract:
Abstract: Organophosphate-induced delayed neuropathy (OPIDN) is a rare clinical condition. It occurs in association with ingestion of large amount of organophosphorus compound. The clinical picture is characterized by transient paraesthesia, tingling, and numbness usually confined to the distal parts of the limbs, describes as gloves and stockings pattern of sensory impairment, followed by symmetrical motor weakness, which is flaccid type, starts distally in the lower limbs first then ascends to involve upper limbs. The sensory and motor disturbances are usually mild and seen distally, but in
APA, Harvard, Vancouver, ISO, and other styles
12

Gautam, Sandesh, Sanjaya Sapkota, Rajeev Ojha, et al. "Delayed myelopathy after organophosphate intoxication: A case report." SAGE Open Medical Case Reports 10 (January 2022): 2050313X2211043. http://dx.doi.org/10.1177/2050313x221104309.

Full text
Abstract:
Organophosphate-induced delayed neuropathy, a central-distal axonopathy, passes through latent, progressive, static and improvement phases. During the improvement phase, the peripheral nerves regenerate unmasking the spinal cord lesion with myelopathic features. We report a case of a 16-year-old male who developed myelopathy 6 weeks following chlorpyrifos poisoning. He had a motor weakness of 4/5 in bilateral hips and 3/5 in bilateral knees and ankles. Spasticity and exaggerated reflexes with ankle clonus were present in the lower limbs. Sensory and the upper limb motor examinations were all n
APA, Harvard, Vancouver, ISO, and other styles
13

Inozemtsev, V. A., I. A. Nelga, I. V. Medvetsky, et al. "History of Foreign Studies of Organophosphate Induced Delayed Neuropathy." Journal of NBC Protection Corps 4, no. 2 (2020): 177–88. http://dx.doi.org/10.35825/2587-5728-2020-4-2-177-188.

Full text
Abstract:
Сertain organophosphates are highly toxic and can be used as chemical warfare agents. However, some classes of organic phosphorus compounds can cause so-called delayed neurotoxicity. Since the discovery of this phenomenon in 1899, extensive research has been conducted on delayed neurotoxicity caused by organophosphates. Mass poisoning of residents of the United States and Morocco in the last century demonstrated the high danger of substances that cause neurotoxicity, and gave a powerful impetus to research into this phenomenon. In addition to delayed effects, some phosphorus compounds potentia
APA, Harvard, Vancouver, ISO, and other styles
14

Thomas, T. C., Y. Ishikawa, M. G. McNamee, and B. W. Wilson. "Correlation of neuropathy target esterase activity with specific tritiated di-isopropyl phosphorofluoridate-labelled proteins." Biochemical Journal 257, no. 1 (1989): 109–16. http://dx.doi.org/10.1042/bj2570109.

Full text
Abstract:
Neuropathy target esterase (NTE) is a membrane-bound carboxylesterase activity that has been proposed as the target site for initiation of organophosphate-induced delayed neuropathy. This activity is identified by its resistance to treatment with Paraoxon and sensitivity to co-incubation with Paraoxon and Mipafox. Sucrose-density-gradient centrifugation of membrane-associated proteins isolated from chick-embryo brains identified three proteins, Mr 161,000, 116,500 and 103,000, that were labelled with [3H]di-isopropyl phosphorofluoridate in an NTE-like manner and that co-migrated with NTE. The
APA, Harvard, Vancouver, ISO, and other styles
15

Malla, SindhuRao, Mahadevaiah Mahesh, ChilkundaRaviprakash Venkatesh, and Varsha Tandure. "Poisoned to paralysed: A case of organophosphate induced delayed neuropathy." Journal of Dr. NTR University of Health Sciences 8, no. 4 (2019): 281. http://dx.doi.org/10.4103/jdrntruhs.jdrntruhs_87_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Moussaoui, Salma, Salma El Ouadih, Anas Orgi, et al. "MRI findings in organophosphate-induced delayed neuropathy: A case report." Radiology Case Reports 20, no. 3 (2025): 1345–49. https://doi.org/10.1016/j.radcr.2024.11.038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Funk, Kathleen A., John D. Henderson, Chen-Hsuan Liu, Robert J. Higgins, and Barry W. Wilson. "Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks." Archives of Toxicology 68, no. 5 (1994): 308–16. http://dx.doi.org/10.1007/s002040050074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Masoud, Anwar, Ravi Kiran, and Rajat Sandhir. "Impaired Mitochondrial Functions in Organophosphate Induced Delayed Neuropathy in Rats." Cellular and Molecular Neurobiology 29, no. 8 (2009): 1245–55. http://dx.doi.org/10.1007/s10571-009-9420-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Song, Fuyong, and Keqin Xie. "Calcium-dependent neutral cysteine protease and organophosphate-induced delayed neuropathy." Chemico-Biological Interactions 200, no. 2-3 (2012): 114–18. http://dx.doi.org/10.1016/j.cbi.2012.10.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kretzschmar, Doris. "PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases." Metabolites 12, no. 4 (2022): 284. http://dx.doi.org/10.3390/metabo12040284.

Full text
Abstract:
Patatin-like phospholipase domain-containing protein 6 (PNPLA6), originally called Neuropathy Target Esterase (NTE), belongs to a family of hydrolases with at least eight members in mammals. PNPLA6/NTE was first identified as a key factor in Organophosphate-induced delayed neuropathy, a degenerative syndrome that occurs after exposure to organophosphates found in pesticides and nerve agents. More recently, mutations in PNPLA6/NTE have been linked with a number of inherited diseases with diverse clinical symptoms that include spastic paraplegia, ataxia, and chorioretinal dystrophy. A conditiona
APA, Harvard, Vancouver, ISO, and other styles
21

Masoud, A., and R. Sandhir. "Increased oxidative stress is associated with the development of organophosphate-induced delayed neuropathy." Human & Experimental Toxicology 31, no. 12 (2012): 1214–27. http://dx.doi.org/10.1177/0960327112446842.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Glynn, Paul. "Axonal Degeneration and Neuropathy Target Esterase." Archives of Industrial Hygiene and Toxicology 58, no. 3 (2007): 355–58. http://dx.doi.org/10.2478/v10004-007-0029-z.

Full text
Abstract:
Axonal Degeneration and Neuropathy Target EsteraseThis brief review summarises recent observations which suggest a possible mechanism for organophosphate-induced delayed neuropathy (OPIDN). Neuropathy target esterase (NTE) has been shown to deacylate endoplasmic reticulum (ER) membrane phosphatidylcholine (PtdCho). Raised levels of PtdCho are present in the brains of swiss cheese/NTE mutant Drosophila together with abnormal membrane structures, axonal and dendritic degeneration and neural cell loss. Similar vacuolated pathology is found in the brains of mice with brain-specific deletion of the
APA, Harvard, Vancouver, ISO, and other styles
23

Doherty, John D. "Screening Pesticides for Neuropathogenicity." Journal of Biomedicine and Biotechnology 2006 (2006): 1–13. http://dx.doi.org/10.1155/jbb/2006/70414.

Full text
Abstract:
Pesticides are routinely screened in studies that follow specific guidelines for possible neuropathogenicity in laboratory animals. These tests will detect chemicals that are by themselves strong inducers of neuropathogenesis if the tested strain is susceptible relative to the time of administration and methodology of assessment. Organophosphate induced delayed neuropathy (OPIDN) is the only known human neurodegenerative disease associated with pesticides and the existing study guidelines with hens are a standard for predicting the potential for organophosphates to cause OPIDN. Although recent
APA, Harvard, Vancouver, ISO, and other styles
24

Lotti, M., A. Moretto, R. Zoppellari, R. Dainese, N. Rizzuto, and G. Barusco. "Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy." Archives of Toxicology 59, no. 3 (1986): 176–79. http://dx.doi.org/10.1007/bf00316329.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Johnson, M. K., and D. J. Read. "Prophylaxis against and promotion of organophosphate-induced delayed neuropathy by phenyl di-n-pentylphosphinate." Chemico-Biological Interactions 87, no. 1-3 (1993): 449–55. http://dx.doi.org/10.1016/0009-2797(93)90074-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Jati, Monalisa, and Ashmeet Kaur. "Isolated Hypoglossal Nerve Palsy: A Rare Complication of Organophosphate Poisoning." Acta Neurologica Taiwanica 33, no. 3 (2024): 123–26. http://dx.doi.org/10.4103/ant.33-3_112_0053.

Full text
Abstract:
Abstract Purpose: This case report aims to describe a rare manifestation of isolated hypoglossal nerve palsy (HNP) resulting from organophosphate poisoning (OP), specifically organophosphate- induced delayed neuropathy (OPIDN). The primary objective of this case report is to highlight this unusual manifestation and discuss its potential underlying mechanisms, emphasizing the importance of timely diagnosis and appropriate management. Case Report: A 31-year-old male with a history of consuming a commercial chlorpyrifos formulation presented with acute organophosphate poisoning symptoms that impr
APA, Harvard, Vancouver, ISO, and other styles
27

Kokshareva, N. V., I. I. Tkachenko, V. E. Krivenchuck, et al. "Experimental correction of the delayed neuropathy induced by organophosphates." Toxicology Letters 88 (October 1996): 22. http://dx.doi.org/10.1016/s0378-4274(96)80079-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Padilla, Stephanie, and Bellina Veronesi. "Biochemical and Morphological Validation of a Rodent Model of Organophosphorus-Induced Delayed Neuropathy." Toxicology and Industrial Health 4, no. 3 (1988): 361–71. http://dx.doi.org/10.1177/074823378800400308.

Full text
Abstract:
Exposure to certain organophosphates (OPs) produces a delayed degeneration of the longest and largest nerve fibers (OPIDN). Until recently, investigators have used the chicken as the primary experimental model of OPIDN. Although the chicken is extremely sensitive to the ataxia associated with this neuropathy, it lacks an extensive biochemical, electrophysiological and pathological data-base. Because of this we set out to develop a rodent model of OPIDN with morphological and biochemical correlates similar to those seen in the chicken. Historically the rat had been labeled insensitive to OPIDN
APA, Harvard, Vancouver, ISO, and other styles
29

Petroianu, G., F. Hardt, M. Toomes, W. Bergler, and R. Rüfer. "High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs." Journal of Applied Toxicology 21, no. 4 (2001): 263–68. http://dx.doi.org/10.1002/jat.752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Honorato de Oliveira, Georgino, Vanessa Moreira, and Sheila Patricia Ribeiro Goes. "Organophosphate induced delayed neuropathy in genetically dissimilar chickens: studies with tri-ortho-cresyl phosphate (TOCP) and trichlorfon." Toxicology Letters 136, no. 2 (2002): 143–50. http://dx.doi.org/10.1016/s0378-4274(02)00295-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Yu-Yuan, Li, and Wu Yi-Jun. "Changes of Neuropathy Target Esterase Affect Phospholipid Homeostasis in SK-N-SH Cells." Revista de Chimie 71, no. 8 (2020): 327–34. http://dx.doi.org/10.37358/rc.20.8.8306.

Full text
Abstract:
Neuropathy target esterase (NTE), is a membrane protein located in the endoplasmic reticulum (ER). NTE has the activity of phospholipase B and can catalyze the deacylation of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) to glycerylcholine (GPC). It is phosphorylated and aged by organophosphorus compounds (OPs), that induce delayed neuropathy in humans and sensitive animals. Our previous study has reported that the disruption of ER phospholipid homeostasis caused by the NTE inhibition may contribute to the initiation of the organophosphate-induced delayed neurotoxicity (OPIDN), wh
APA, Harvard, Vancouver, ISO, and other styles
32

Knoll-Gellida, Anja, Leslie E. Dubrana, Laure M. Bourcier, et al. "Hyperactivity and Seizure Induced by Tricresyl Phosphate Are Isomer Specific and Not Linked to Phenyl Valerate-Neuropathy Target Esterase Activity Inhibition in Zebrafish." Toxicological Sciences 180, no. 1 (2021): 160–74. http://dx.doi.org/10.1093/toxsci/kfab006.

Full text
Abstract:
Abstract Environmental exposure to tricresyl phosphate (TCP) may lead to severe neurotoxic effects, including organophosphate (OP)-induced delayed neuropathy. TCP has three symmetric isomers, distinguished by the methyl group position on the aromatic ring system. One of these isomers, tri-ortho-cresyl phosphate (ToCP), has been reported for years as a neuropathic OP, targeting neuropathic target esterase (NTE/PNPLA6), but its mode of toxic action had not been fully elucidated. Zebrafish eleuthero-embryo and larva were used to characterize the differential action of the TCP isomers. The symmetr
APA, Harvard, Vancouver, ISO, and other styles
33

Makhaeva, Galina F., Vladimir V. Malygin, Nadezhda N. Strakhova, et al. "Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress." Human & Experimental Toxicology 26, no. 4 (2007): 273–82. http://dx.doi.org/10.1177/0960327106070463.

Full text
Abstract:
Organophosphates (OPs) that inhibit neuropathy target esterase (NTE) with subsequent ageing can produce OP-induced delayed neuropathy (OPIDN). NTE inhibition in lymphocytes can be used as a biomarker of exposure to neuropathic OPs. An electrochemical method was developed to assay NTE in whole blood. The high sensitivity of the tyrosinase carbon-paste biosensors for the phenol produced by hydrolysis of the substrate, phenyl valerate, allowed NTE activity to be measured in diluted samples of whole blood, which cannot be done using the standard colorimetric assay. The biosensor was used to establ
APA, Harvard, Vancouver, ISO, and other styles
34

Masoud, Anwar, Ravi Kiran, and Rajat Sandhir. "Modulation of dopaminergic system and neurobehavioral functions in delayed neuropathy induced by organophosphates." Toxicology Mechanisms and Methods 21, no. 1 (2010): 1–5. http://dx.doi.org/10.3109/15376516.2010.529182.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Johnson, M. K., I. Bird, and C. Meredith. "Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathy." Toxicology Letters 40, no. 2 (1988): 133–40. http://dx.doi.org/10.1016/0378-4274(88)90154-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Choudhary, Sanjeev, and Kiran Dip Gill. "Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain11Abbreviations: OP, organophosphate; NTE, neuropathy target esterase; OPIDN, organophosphate-induced delayed neuropathy; PAM, 2-pyridine aldoxime methiodide; SPM, synaptic plasma membranes; VOCC, voltage-operated calcium channels; TOCP, tri-o-cresyl phosphate; PSP, phenyl saligenin phosphate; and [Ca2+]i, intracellular calcium." Biochemical Pharmacology 62, no. 9 (2001): 1265–72. http://dx.doi.org/10.1016/s0006-2952(01)00762-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Luo, Fang, Aaron F. Sandhu, Wiramon Rungratanawanich, et al. "Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases." International Journal of Molecular Sciences 21, no. 19 (2020): 7174. http://dx.doi.org/10.3390/ijms21197174.

Full text
Abstract:
With aging, the nervous system gradually undergoes degeneration. Increased oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and cell death are considered to be common pathophysiological mechanisms of various neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), organophosphate-induced delayed neuropathy (OPIDN), and amyotrophic lateral sclerosis (ALS). Autophagy is a cellular basic metabolic process that degrades the aggregated or misfolded proteins and abnormal organelles in cells. The abnormal regula
APA, Harvard, Vancouver, ISO, and other styles
38

Kelly, Sean S., Gail E. de Blaquière, Faith M. Williams, and Peter G. Blain. "Effects of multiple doses of organophosphates on evoked potentials in mouse diaphragm." Human & Experimental Toxicology 16, no. 2 (1997): 72–78. http://dx.doi.org/10.1177/096032719701600202.

Full text
Abstract:
1 Male albino mice were injected s.c. with an organopho sphate (mipafox, ecothiopate or paraoxon). Treat ments were either a single injection or multiple daily injections with lower doses for 5 or 8 days. At 3 h after injection the activity of brain and diaphragm acet ylcholinesterase and of brain neuropathy target esterase (NTE) was measured. Also measured in the diaphragm at 3 h post dose was the duration of spontaneous miniature endplate potentials (eMEPPs), recorded extracellularly. 2 At 7 and 28 days after dosing action potentials and evoked endplate potentials, produced by stimulating th
APA, Harvard, Vancouver, ISO, and other styles
39

Chuang, Chia-Chang, Thy-Sheng Lin, and Ming-Che Tsai. "Delayed Neuropathy and Myelopathy after Organophosphate Intoxication." New England Journal of Medicine 347, no. 14 (2002): 1119–21. http://dx.doi.org/10.1056/nejm200210033471421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Lotti, Marcello, and Angelo Moretto. "Organophosphate-Induced Delayed Polyneuropathy." Toxicological Reviews 24, no. 1 (2005): 37–49. http://dx.doi.org/10.2165/00139709-200524010-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Jokanovic, Milan, Melita Kosanovic, and Petar Stukalov. "Organophosphate Induced Delayed Polyneuropathy." Medicinal Chemistry Reviews - Online 1, no. 2 (2004): 123–31. http://dx.doi.org/10.2174/1567203043480377.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Milan Jokanovic, Bentham Science Publisher, Bentham Science Publisher Petar V. Stukalov, and Bentham Science Publisher Melita Kosanovic. "Organophosphate Induced Delayed Polyneuropathy." Current Drug Target -CNS & Neurological Disorders 1, no. 6 (2002): 593–602. http://dx.doi.org/10.2174/1568007023338879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Gutmann, Ludwig, and John B. Bodensteiner. "Organophosphate-induced delayed polyneuropathy." Journal of Pediatrics 123, no. 5 (1993): 837. http://dx.doi.org/10.1016/s0022-3476(05)80877-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Dirik, Eray, and Kamer Mutafoğlu Uysal. "Organophosphate-induced delayed polyneuropathy." Pediatric Neurology 11, no. 2 (1994): 111. http://dx.doi.org/10.1016/0887-8994(94)90247-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Coskun, Abuzer, Afsin Emre Kayipmaz, Sedat Ozbay, Osman Mahir Okur, Ilham Ozkan, and Sevki Hakan Eren. "Delayed organophosphate - induced polyneuropathy." Medical Science and Discovery 2, no. 4 (2019): 271–74. https://doi.org/10.36472/msd.v2i4.70.

Full text
Abstract:
Introduction: Intoxication with organophosphate compounds used for pest control is common in Turkey. Organophosphate intoxication may occur during agricultural spraying, transport of organophosphate compounds, or domestic accidents, although suicide attempts are the most common way of intoxication. Case Presentation: We present a 23-year-old woman ingested a fistful of painkillers and drank a sip of an unknown syrup after having a quarrel with her family. Four hours later, she had been taken to a nearby hospital with nausea, vomiting, and abdominal pain, where she had been treated for drug int
APA, Harvard, Vancouver, ISO, and other styles
46

Chen, Chiao-Chien, and Lin-Fen Hsieh. "Delayed Neuropathy Due to Organophosphate Intoxication: A casereport." Rehabilitation Practice and Science 33, no. 4 (2005): 235–43. http://dx.doi.org/10.6315/2005.33(4)07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Karademir, M., F. Ertürk, and R. Koçak. "Two Cases of Organophosphate Poisoning with Development of Intermediate Syndrome." Human & Experimental Toxicology 9, no. 3 (1990): 187–89. http://dx.doi.org/10.1177/096032719000900312.

Full text
Abstract:
Two cases of intermediate syndrome caused by organophosphorus poisoning are reported. Trichlorfon, propoxur (a carbamate pesticide) and fenthion were ingested in both attempts at suicide. After successful conventional therapy during the cholinergic phase, but before the time when the onset of delayed neuropathy might be expected, an intermediate syndrome developed. It affected the proximal limb muscles, neck flexors and respiratory muscles 2 d after pesticide ingestion. The two patients needed respiratory support. Recovery from the intermediate syndrome was complete in both patients, although
APA, Harvard, Vancouver, ISO, and other styles
48

Zhminko, Peter, and Natali Kokshareva. "Organophosphate-induced neuropathy and its experimental correction." Toxicology Letters 211 (June 2012): S137. http://dx.doi.org/10.1016/j.toxlet.2012.03.500.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Kobayashi, Shunsuke, Reiko Okubo, and Yoshikazu Ugawa. "Delayed Polyneuropathy Induced by Organophosphate Poisoning." Internal Medicine 56, no. 14 (2017): 1903–5. http://dx.doi.org/10.2169/internalmedicine.56.7921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Moretto, Angelo. "Testing for Organophosphate-Induced Delayed Polyneuropathy." Current Protocols in Toxicology 00, no. 1 (1999): 11.5.1–11.5.14. http://dx.doi.org/10.1002/0471140856.tx1105s00.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!